The board will now expand with the addition of Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation, Nicole Seligman, former president of Sony Entertainment, and Instacart CEO Fidji Simo.
bluebird bio, Inc. (BLUE) has signed first Medicaid outcomes-based agreement for LYFGENIA with the state of Michigan. LYFGENIA is a one-time gene therapy approved for the treatment of patients 12 years of age and older with sickle cell disease and a history of vaso-occlusive events.
Sam Altman is rejoining the board
of ChatGPT-maker OpenAI along with three new directors, as the
startup tries to move past his sudden ouster in November that
had shocked the tech industry. .
OpenAI CEO Altman wasn't fired because of scary new tech, just internal politics arstechnica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arstechnica.com Daily Mail and Mail on Sunday newspapers.
Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster in November that shocked the tech industry.